Progress and prospects: hurdles to cardiovascular gene therapy clinical trials.
about
Gene therapy for cardiovascular disease: advances in vector development, targeting, and delivery for clinical translationGene delivery technologies for cardiac applicationsTherapeutic angiogenesis: controlled delivery of angiogenic factors.The road ahead: working towards effective clinical translation of myocardial gene therapies.Inducing gene expression by targeting promoter sequences using small activating RNAs.A parallel wire robot for epicardial interventions.Increased erythropoiesis in mice injected with submicrogram quantities of pseudouridine-containing mRNA encoding erythropoietin.Toward hybrid force/position control for the Cerberus epicardial robotThe Use of Gene Therapy for Ablation of Atrial Fibrillation.Integrase-deficient lentiviral vectors mediate efficient gene transfer to human vascular smooth muscle cells with minimal genotoxic risk.Parallel Force/Position Control of an Epicardial Parallel Wire Robot.Pro- and anti-angiogenic therapy and atherosclerosis with special emphasis on vascular endothelial growth factors.Promoting blood vessel growth in ischemic diseases: challenges in translating preclinical potential into clinical success.Percutaneous approaches for efficient cardiac gene delivery.A New Gene Therapy Approach for Cardiovascular Disease by Non-coding RNAs Acting in the Nucleus.Current Methods in Cardiac Gene Therapy: Overview.The basis for the distinct biological activities of vascular endothelial growth factor receptor-1 ligands.Gene Therapy in the Nervous System: Failures and Successes.Gene transfer to promote cardiac regeneration.Efficacy and safety of myocardial gene transfer of adenovirus, adeno-associated virus and lentivirus vectors in the mouse heart.Neovascularization in tissue engineering.Long-term miR-669a therapy alleviates chronic dilated cardiomyopathy in dystrophic mice.MicroRNA based treatment of cardiomyopathy: not all dystrophies are created equal.Molecular Cardiac Surgery with Recirculating Delivery (MCARD): Procedure and Vector Transfer.Angiogenic gene therapy in cardiovascular diseases: dream or vision?A short discourse on vascular tissue engineering.
P2860
Q26799437-16656A78-0ABB-41EB-A3A1-C4BBBFDD4FD0Q26863362-78B60EE0-A047-4CB0-83AA-4066E171F3B9Q27023731-3A999DAC-DA78-4D9D-B202-3FFB0A94C5D8Q33705144-41F37A2E-3847-4D3C-832E-FE9CF506E4F3Q34470117-C48D6166-1040-4F39-BE38-D32C41C461E5Q35178257-BE0313B2-87D1-4D28-B268-FCF7C86A6231Q35939486-F943BA4E-1829-4B1F-9C0B-4D838D83E28EQ36438895-F1048126-B579-4991-89E6-6C136FEFB0E0Q36458906-5288D82D-FB07-4FBF-90D6-667ADC9D577BQ36469473-AACE5180-AD69-4BDC-AEC0-4D75FE53A71CQ36992680-462605FD-EBE6-455F-BE33-0E4736741157Q37960607-FC8065C6-A2CB-49D1-90DD-512ECCE5B799Q38087578-8747EEA9-9DAE-4462-824D-955080EA74E6Q38113171-B023AE0C-E3F9-42E2-B5CF-B435AD4AF01DQ38269076-713103B8-1C2F-4283-ABF0-8B3B15358859Q38788217-E2A9027C-128F-4A79-A2C0-B4A5025828A0Q39131192-0B1CACF0-3D50-4505-A4BF-84CC820D7B35Q40070708-E7A1D330-E144-4930-9066-3B7EBE18EB47Q40802294-5FA3983A-B89E-4950-9AFB-080609EBE8CEQ41021093-A8C1D73F-20CB-4791-801C-4BFFFB73F112Q41889561-2689BFC2-AC79-4725-B2F0-292066D94127Q42275401-EBB2ABCC-D53E-4687-9202-0B22FB79FE47Q42906190-409EC768-2EE4-4EC9-90C3-9D4D36316BA9Q45862464-2C7D6847-564A-48C1-9C68-0506002D3EC6Q45863499-64BB1A02-2DC7-44D2-80FD-05033CDAC427Q52924173-DB9CFD5F-E467-4CBE-A96E-BB9372B3B38D
P2860
Progress and prospects: hurdles to cardiovascular gene therapy clinical trials.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 14 April 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Progress and prospects: hurdles to cardiovascular gene therapy clinical trials.
@en
Progress and prospects: hurdles to cardiovascular gene therapy clinical trials.
@nl
type
label
Progress and prospects: hurdles to cardiovascular gene therapy clinical trials.
@en
Progress and prospects: hurdles to cardiovascular gene therapy clinical trials.
@nl
prefLabel
Progress and prospects: hurdles to cardiovascular gene therapy clinical trials.
@en
Progress and prospects: hurdles to cardiovascular gene therapy clinical trials.
@nl
P2860
P356
P1433
P1476
Progress and prospects: hurdles to cardiovascular gene therapy clinical trials.
@en
P2093
J Hartikainen
P2860
P2888
P304
P356
10.1038/GT.2011.43
P577
2011-04-14T00:00:00Z